Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Etanercept for psoriasis: two case reports.

A Fidalgo1, J Baptista, F Rocha Páris

  • 1Dermatology Department, Desterro Hospital, Lisbon, Portugal. ana.fidalgo@netcabo.pt

International Journal of Clinical Pharmacology Research
|January 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated extraction of temporalized tumor evolution from oncology EMRs using natural language processing.

ESMO real world data and digital oncology·2026
Same author

Laminaria tent use for dilation, extraction, and curettage leading to septic shock: a case report.

Journal of medical case reports·2025
Same author

Biometric and biochemical characterization for potential uses of Euterpe edulis (Martius) seeds.

Brazilian journal of biology = Revista brasleira de biologia·2025
Same author

Variation in the diet composition and weight-length relationship of small characids in urbanized and forested streams.

Journal of fish biology·2025
Same author

Physiological quality of seeds of arabic coffee cultivars stored for a period of two years.

Brazilian journal of biology = Revista brasleira de biologia·2024
Same author

Potential of coffee straw biochal as a substrate conditioner in seed lettuce and sorghum germination and vigority.

Brazilian journal of biology = Revista brasleira de biologia·2024
Same journal

Breath alcohol concentrations in Japanese outpatients following paclitaxel and docetaxel infusion.

International journal of clinical pharmacology research·2006
Same journal

Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.

International journal of clinical pharmacology research·2006
Same journal

The effect of D-003 (10 mg/day) on biochemical parameters of bone remodelling in postmenopausal women: a randomized, double-blind study.

International journal of clinical pharmacology research·2006
Same journal

Evaluation of cytokine serum levels in patients with plaque-type psoriasis.

International journal of clinical pharmacology research·2006
Same journal

Treatment of guttate psoriasis with a new two-compound product containing calcipotriol and betamethasone dipropionate.

International journal of clinical pharmacology research·2006
Same journal

Evaluation of hepatitis B surface antigen, anti-hepatitis C virus and anti-human immunodeficiency virus antibodies and syphilis seropositivity in blood donors: six years' seropositivity.

International journal of clinical pharmacology research·2005
See all related articles

Etanercept, a biologic targeting tumor necrosis factor-alpha (TNF-alpha), effectively treated severe psoriasis and psoriatic arthritis in two cases. This TNF antagonism approach showed remarkable improvement with no adverse events.

Area of Science:

  • Immunodermatology
  • Rheumatology
  • Pharmacology

Background:

  • Psoriasis is a chronic T-cell mediated inflammatory skin disease.
  • Tumor necrosis factor-alpha (TNF-alpha) plays a key role in psoriasis pathogenesis.
  • Biological agents offer targeted therapies for conventional systemic medication alternatives.

Observation:

  • Two patients with severe, recalcitrant psoriasis and psoriatic arthritis were treated.
  • Etanercept, a TNF-alpha inhibitor, was administered to the patients.
  • Treatment outcomes were monitored for efficacy and adverse events.

Findings:

  • Both patients experienced remarkable improvement in their severe psoriasis and arthritis.
  • Etanercept demonstrated significant efficacy in managing treatment-resistant cases.

Related Experiment Videos

  • No adverse events were reported during the treatment period.

    • Implications:

    • TNF antagonism with etanercept is a promising therapeutic strategy for severe psoriasis and psoriatic arthritis.
    • This approach offers an effective alternative for patients unresponsive to traditional treatments.
    • Further research into etanercept's long-term efficacy and safety in psoriasis is warranted.